 | • レポートコード：MRC2-11QY04111 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は変形性関節症治療のグローバル市場について調査・分析したレポートです。種類別（薬物、支援機器）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別変形性関節症治療の競争状況、市場シェア ・世界の変形性関節症治療市場：種類別市場規模 2015年-2020年（薬物、支援機器） ・世界の変形性関節症治療市場：種類別市場規模予測 2021年-2026年（薬物、支援機器） ・世界の変形性関節症治療市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界の変形性関節症治療市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米の変形性関節症治療市場分析：米国、カナダ ・ヨーロッパの変形性関節症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの変形性関節症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の変形性関節症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの変形性関節症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Johnson & Johnson、Novartis、GlaxoSmithKline、Zimmer Biomet、Stryker、Abbott ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Osteoarthritis (OA) is a type of joint disease that results from breakdown of joint cartilage and underlying bone. The most common symptoms are joint pain and stiffness. Initially, symptoms may occur only following exercise, but over time may become constant. Other symptoms may include joint swelling, decreased range of motion, and, when the back is affected, weakness or numbness of the arms and legs. The most commonly involved joints are those near the ends of the fingers, at the base of the thumb, neck, lower back, knee, and hips. Joints on one side of the body are often more affected than those on the other. Usually the symptoms come on over years. It can affect work and normal daily activities. Unlike other types of arthritis, only the joints are typically affected.
Owing to the growing lifestyle changes, increasing number of obesity cases, and an extensive rise in the geriatric population, cases of osteoarthritis are increasing in North America. As a result, the adoption of treatment and drugs is also increasing in the region. The availability of better treatment options, high awareness among the people, government reimbursement policies, and the willingness to take up treatment is expected to add up to the growth of the osteoarthritis treatment market in the region. In terms of the business opportunities, the U.S., Europe, and Asia Pacific are lucrative markets for osteoarthritis treatment and drugs due to high prevalence of the disease. Alternative and complementary medicines are of great interest to the patient population affected by osteoarthritis. In the U.S., alternative medicine segments are growing at a higher pace and have high potential for substantial research. Due to advancements in technology, osteoarthritis management becomes more focused towards effective treatment and this is expected to fuel the growth of the global osteoarthritis treatment market in the long run.
Market Analysis and Insights: Global Osteoarthritis Treatment Market
The global Osteoarthritis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Osteoarthritis Treatment Scope and Market Size
Osteoarthritis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Osteoarthritis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Johnson & Johnson
Novartis
GlaxoSmithKline
Zimmer Biomet
Stryker
Abbott
…
Market segment by Type, the product can be split into
Drugs
Assistive Devices
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Osteoarthritis Treatment Revenue
1.4 Market by Type
1.4.1 Global Osteoarthritis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Drugs
1.4.3 Assistive Devices
1.5 Market by Application
1.5.1 Global Osteoarthritis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Osteoarthritis Treatment Market Perspective (2015-2026)
2.2 Global Osteoarthritis Treatment Growth Trends by Regions
2.2.1 Osteoarthritis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Osteoarthritis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Osteoarthritis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Osteoarthritis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Osteoarthritis Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Osteoarthritis Treatment Players by Market Size
3.1.1 Global Top Osteoarthritis Treatment Players by Revenue (2015-2020)
3.1.2 Global Osteoarthritis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Osteoarthritis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Osteoarthritis Treatment Market Concentration Ratio
3.2.1 Global Osteoarthritis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Osteoarthritis Treatment Revenue in 2019
3.3 Osteoarthritis Treatment Key Players Head office and Area Served
3.4 Key Players Osteoarthritis Treatment Product Solution and Service
3.5 Date of Enter into Osteoarthritis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Osteoarthritis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Osteoarthritis Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Osteoarthritis Treatment Market Size by Application (2015-2020)
5.2 Global Osteoarthritis Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Osteoarthritis Treatment Market Size (2015-2020)
6.2 Osteoarthritis Treatment Key Players in North America (2019-2020)
6.3 North America Osteoarthritis Treatment Market Size by Type (2015-2020)
6.4 North America Osteoarthritis Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Osteoarthritis Treatment Market Size (2015-2020)
7.2 Osteoarthritis Treatment Key Players in Europe (2019-2020)
7.3 Europe Osteoarthritis Treatment Market Size by Type (2015-2020)
7.4 Europe Osteoarthritis Treatment Market Size by Application (2015-2020)
8 China
8.1 China Osteoarthritis Treatment Market Size (2015-2020)
8.2 Osteoarthritis Treatment Key Players in China (2019-2020)
8.3 China Osteoarthritis Treatment Market Size by Type (2015-2020)
8.4 China Osteoarthritis Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Osteoarthritis Treatment Market Size (2015-2020)
9.2 Osteoarthritis Treatment Key Players in Japan (2019-2020)
9.3 Japan Osteoarthritis Treatment Market Size by Type (2015-2020)
9.4 Japan Osteoarthritis Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Osteoarthritis Treatment Market Size (2015-2020)
10.2 Osteoarthritis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Osteoarthritis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Osteoarthritis Treatment Market Size by Application (2015-2020)
11 India
11.1 India Osteoarthritis Treatment Market Size (2015-2020)
11.2 Osteoarthritis Treatment Key Players in India (2019-2020)
11.3 India Osteoarthritis Treatment Market Size by Type (2015-2020)
11.4 India Osteoarthritis Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Osteoarthritis Treatment Market Size (2015-2020)
12.2 Osteoarthritis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Osteoarthritis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Osteoarthritis Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Osteoarthritis Treatment Introduction
13.1.4 Pfizer Revenue in Osteoarthritis Treatment Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview
13.2.3 Johnson & Johnson Osteoarthritis Treatment Introduction
13.2.4 Johnson & Johnson Revenue in Osteoarthritis Treatment Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Osteoarthritis Treatment Introduction
13.3.4 Novartis Revenue in Osteoarthritis Treatment Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview
13.4.3 GlaxoSmithKline Osteoarthritis Treatment Introduction
13.4.4 GlaxoSmithKline Revenue in Osteoarthritis Treatment Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Zimmer Biomet
13.5.1 Zimmer Biomet Company Details
13.5.2 Zimmer Biomet Business Overview
13.5.3 Zimmer Biomet Osteoarthritis Treatment Introduction
13.5.4 Zimmer Biomet Revenue in Osteoarthritis Treatment Business (2015-2020)
13.5.5 Zimmer Biomet Recent Development
13.6 Stryker
13.6.1 Stryker Company Details
13.6.2 Stryker Business Overview
13.6.3 Stryker Osteoarthritis Treatment Introduction
13.6.4 Stryker Revenue in Osteoarthritis Treatment Business (2015-2020)
13.6.5 Stryker Recent Development
13.7 Abbott
13.7.1 Abbott Company Details
13.7.2 Abbott Business Overview
13.7.3 Abbott Osteoarthritis Treatment Introduction
13.7.4 Abbott Revenue in Osteoarthritis Treatment Business (2015-2020)
13.7.5 Abbott Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Osteoarthritis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Osteoarthritis Treatment Revenue
Table 3. Ranking of Global Top Osteoarthritis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Osteoarthritis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drugs
Table 6. Key Players of Assistive Devices
Table 7. Global Osteoarthritis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Osteoarthritis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Osteoarthritis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Osteoarthritis Treatment Market Share by Regions (2015-2020)
Table 11. Global Osteoarthritis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Osteoarthritis Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Osteoarthritis Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Osteoarthritis Treatment Players
Table 18. Global Osteoarthritis Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Osteoarthritis Treatment Market Share by Players (2015-2020)
Table 20. Global Top Osteoarthritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoarthritis Treatment as of 2019)
Table 21. Global Osteoarthritis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Osteoarthritis Treatment Product Solution and Service
Table 24. Date of Enter into Osteoarthritis Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Osteoarthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Osteoarthritis Treatment Market Size Share by Type (2015-2020)
Table 28. Global Osteoarthritis Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Osteoarthritis Treatment Market Size Share by Application (2015-2020)
Table 30. Global Osteoarthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Osteoarthritis Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Osteoarthritis Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Osteoarthritis Treatment Market Share (2019-2020)
Table 34. North America Osteoarthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Osteoarthritis Treatment Market Share by Type (2015-2020)
Table 36. North America Osteoarthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Osteoarthritis Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Osteoarthritis Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Osteoarthritis Treatment Market Share (2019-2020)
Table 40. Europe Osteoarthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Osteoarthritis Treatment Market Share by Type (2015-2020)
Table 42. Europe Osteoarthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Osteoarthritis Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Osteoarthritis Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Osteoarthritis Treatment Market Share (2019-2020)
Table 46. China Osteoarthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Osteoarthritis Treatment Market Share by Type (2015-2020)
Table 48. China Osteoarthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Osteoarthritis Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Osteoarthritis Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Osteoarthritis Treatment Market Share (2019-2020)
Table 52. Japan Osteoarthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Osteoarthritis Treatment Market Share by Type (2015-2020)
Table 54. Japan Osteoarthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Osteoarthritis Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Osteoarthritis Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Osteoarthritis Treatment Market Share (2019-2020)
Table 58. Southeast Asia Osteoarthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Osteoarthritis Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Osteoarthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Osteoarthritis Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Osteoarthritis Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Osteoarthritis Treatment Market Share (2019-2020)
Table 64. India Osteoarthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Osteoarthritis Treatment Market Share by Type (2015-2020)
Table 66. India Osteoarthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Osteoarthritis Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Osteoarthritis Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Osteoarthritis Treatment Market Share (2019-2020)
Table 70. Central & South America Osteoarthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Osteoarthritis Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Osteoarthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Osteoarthritis Treatment Market Share by Application (2015-2020)
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in Osteoarthritis Treatment Business (2015-2020) (Million US$)
Table 78. Pfizer Recent Development
Table 79. Johnson & Johnson Company Details
Table 80. Johnson & Johnson Business Overview
Table 81. Johnson & Johnson Product
Table 82. Johnson & Johnson Revenue in Osteoarthritis Treatment Business (2015-2020) (Million US$)
Table 83. Johnson & Johnson Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Product
Table 87. Novartis Revenue in Osteoarthritis Treatment Business (2015-2020) (Million US$)
Table 88. Novartis Recent Development
Table 89. GlaxoSmithKline Company Details
Table 90. GlaxoSmithKline Business Overview
Table 91. GlaxoSmithKline Product
Table 92. GlaxoSmithKline Revenue in Osteoarthritis Treatment Business (2015-2020) (Million US$)
Table 93. GlaxoSmithKline Recent Development
Table 94. Zimmer Biomet Company Details
Table 95. Zimmer Biomet Business Overview
Table 96. Zimmer Biomet Product
Table 97. Zimmer Biomet Revenue in Osteoarthritis Treatment Business (2015-2020) (Million US$)
Table 98. Zimmer Biomet Recent Development
Table 99. Stryker Company Details
Table 100. Stryker Business Overview
Table 101. Stryker Product
Table 102. Stryker Revenue in Osteoarthritis Treatment Business (2015-2020) (Million US$)
Table 103. Stryker Recent Development
Table 104. Abbott Company Details
Table 105. Abbott Business Overview
Table 106. Abbott Product
Table 107. Abbott Revenue in Osteoarthritis Treatment Business (2015-2020) (Million US$)
Table 108. Abbott Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Osteoarthritis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Drugs Features
Figure 3. Assistive Devices Features
Figure 4. Global Osteoarthritis Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Osteoarthritis Treatment Report Years Considered
Figure 9. Global Osteoarthritis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Osteoarthritis Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Osteoarthritis Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Osteoarthritis Treatment Market Share by Players in 2019
Figure 14. Global Top Osteoarthritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoarthritis Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Osteoarthritis Treatment Revenue in 2019
Figure 16. North America Osteoarthritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Osteoarthritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Osteoarthritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Osteoarthritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Osteoarthritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Osteoarthritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Osteoarthritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
変形性関節症鎮痛薬の世界市場（～2026年） Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis. Geographically, the global Drugs for Osteoarthritis Pain market has been segmented into North America, Europe, China, Japan, Rest of Asia (RoA), and Re…- 変形性関節症における幹細胞治療の世界市場（～2026年） Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe. The expected growth is beca…
- ドライアイ治療薬・装置治療の世界市場（～2026年） Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry e…
- 変形性関節症再生治療の世界市場（～2026年） Osteoarthritis is a type of joint disease that results from breakdown of joint cartilage and underlying bone. The increasing incidence of osteoarthritis is expected to drive the regenerative therapies for osteoarthritis market. Market Analysis and Insights: Global Regenerative Therapies for Osteoart…
- バーター症候群治療の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. The global market for Bartter syndrome treatment is expected to witness a moderate growth rate over the forecast period. Market Analysis and Insights: Global Bartter Syndrome Treatment Market The global Bart…